Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
Key facts
- Where
- Augusta, Baltimore, Boston, Chapel Hill, Cleveland, Dallas, Durham, Gainesville, Hackensack, Indianapolis, Lebanon, Los Angeles, Madison, Murray, Norfolk, Philadelphia, Plano, Seattle, Stanford, Tampa, Tucson, and Washington D.C., United StatesSee the 24 sites
Where in United States
- Augusta UniversityAugusta, United StatesContact: Yvonne Site CoordinatorTaking people
- University of Maryland, BaltimoreBaltimore, United StatesContact: Langford Site CoordinatorTaking people
- Beth Israel Deaconess Medical CenterBoston, United StatesContact: Fernando Site CoordinatorNot yet recruiting
- University of North Carolina at Chapel HillChapel Hill, United StatesContact: Amber Site CoordinatorTaking people
- University Hospitals Cleveland Medical Center*Cleveland, United StatesContact: Camille Site CoordinatorTaking people
- Baylor Research InstituteDallas, United StatesContact: Sarah Site CoordinatorTaking people
- Duke UniversityDurham, United StatesContact: Hillary Site CoordinatorTaking people
- University of Florida - GainesvilleGainesville, United StatesContact: Nancy Site CoordinatorTaking people
- Hackensack University Medical CenterHackensack, United StatesContact: Stephanie Site CoordinatorTaking people
- Indiana University School of MedicineIndianapolis, United StatesContact: Terri StricklandTaking people
- The Hitchcock Foundation at Dartmouth Hitchcock Medical CenterLebanon, United StatesContact: Paulene Site CoordinatorTaking people
- Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Ayda Site CoordinatorTaking people
- University of Southern CaliforniaLos Angeles, United StatesContact: Stephanie Site CoordinatorTaking people
- University of WisconsinMadison, United StatesContact: Nicole Site CoordinatorTaking people
- Intermountain Medical CenterMurray, United StatesContact: Lexi Site CoordinatorTaking people
- Sentara Medical Group, Sentara Norfolk General HospitalNorfolk, United StatesContact: Kara Site CoordinatorTaking people
- Thomas Jefferson UniversityPhiladelphia, United StatesContact: Ashley Site CoordinatorNot yet recruiting
- University of PennsylvaniaPhiladelphia, United StatesContact: Carolina Site CoordinatorNot yet recruiting
- Columbia Medical Center of PlanoPlano, United StatesContact: Pauline Site CoordinatorTaking people
- University of WashingtonSeattle, United StatesContact: Allison Site CoordinatorNot yet recruiting
- Leland Stanford Junior UniversityStanford, United StatesContact: Suneetha Site CoordinatorTaking people
- University of South FloridaTampa, United StatesContact: Avennette Site CoordinatorTaking people
- University of ArizonaTucson, United StatesContact: Karen Site CoordinatorTaking people
- MedStar Health, MedStar Washington Hospital CenterWashington D.C., United StatesContact: Kassaye Site CoordinatorNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- W.L.Gore & Associates
- Trial code
- NCT06658730
- Record updated
- 19 August 2026
- Original description
An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical practice. This post-market registry for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CTAG w/AC) is intended to demonstrate that thoracic endovascular aortic repair (TEVAR) for lesions of the descending thoracic aorta continues to be a suitable treatment option for appropriately selected patients.Read full original descriptionShow less
An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical practice. This post-market registry for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CTAG w/AC) is intended to demonstrate that thoracic endovascular aortic repair (TEVAR) for lesions of the descending thoracic aorta continues to be a suitable treatment option for appropriately selected patients.
Inclusion: Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements; Patient has been or is intended to be treated with an eligible registry device.*; Patient is age ≥ 18 years at time of informed consent signature; The intent to treat a patient with a Gore product must be made prior to soliciting for possible registry participation. If pre-procedure consent is not feasible due to emergent situation, consent prior to the time of discharge for the index procedure is acceptable.
Exclusion: Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study* within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol; The term "study" does not apply to other observational registries or quality improvement projects. Collection of Registry Device performance from interventional studies may be permissible provided device application is not investigational and there are no novel requirements that alter follow-up conduct (i.e., protocol-mandated interventions); Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures; Patient with exclusion criteria required by local law.